A former Lioness and professional Manchester footballer has turned to the First Dates team as she is on the lookout for love. The BAFTA-winning dating show is set to make its return for a brand new ...

The tumor necrosis factor (TNF)-α-induced protein 8-like 2 (TIPE2), predominantly expressed in bone marrow-derived cells or lymphoid tissues, is an essential regulator of immune homeostasis. TIPE2 ...

Index modulation (IM) has emerged as a promising technique for improving spectral efficiency and hardware efficiency in next-generation communication ...

By Lisa Thompson NASDAQ: POET READ THE FULL POET RESEARCH REPORT With $430 million in cash and the ability to fund capex out of interest income, POET (NASDAQ: POET) is honing its strategy and is ...

Relutrigine, a novel sodium channel modulator, is under FDA Priority Review for the treatment of pediatric SCN2A and SCN8A epileptic encephalopathies.

Modulator pills transformed cystic fibrosis care. But the fight for a cure is not over — so long as research remains funded.

SPG601 is a first-in-class, BK-modulator with the potential to improve cognitive, emotional and sensory symptoms in FXS patients FRAXA's early preclinical support helped establish the ...

PVP Labs, a biotechnology pioneer specializing in peptide-based drug development, today announced its selection to present at the LSX Investival Showcase USA, taking place March 10-11, 2026, in Miami, ...

Please provide your email address to receive an email when new articles are posted on . Poor tolerability and low efficacy impede ethosuximide’s use in the treatment of IBS-related abdominal pain.

When a scrappy team of scientists joined forces in the late 1990s, they sought to identify genetic mutations that could have an outsized impact on the treatment of human disease. At the time, that ...